168 related articles for article (PubMed ID: 16411141)
1. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
Yoshida K; Tomita Y; Okuda Y; Yamamoto S; Enomoto H; Uyama H; Ito H; Hoshida Y; Aozasa K; Nagano H; Sakon M; Kawase I; Monden M; Nakamura H
Ann Surg Oncol; 2006 Feb; 13(2):159-67. PubMed ID: 16411141
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
[TBL] [Abstract][Full Text] [Related]
5. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
[TBL] [Abstract][Full Text] [Related]
6. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
[TBL] [Abstract][Full Text] [Related]
7. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
9. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
Uyama H; Tomita Y; Nakamura H; Nakamori S; Zhang B; Hoshida Y; Enomoto H; Okuda Y; Sakon M; Aozasa K; Kawase I; Hayashi N; Monden M
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6043-8. PubMed ID: 17062679
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
12. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma.
Nagaoka S; Yatsuhashi H; Hamada H; Yano K; Matsumoto T; Daikoku M; Arisawa K; Ishibashi H; Koga M; Sata M; Yano M
Cancer; 2003 Dec; 98(12):2671-7. PubMed ID: 14669288
[TBL] [Abstract][Full Text] [Related]
13. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
14. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
[TBL] [Abstract][Full Text] [Related]
15. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
[TBL] [Abstract][Full Text] [Related]
17. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
